Loading...
The company posted a $557 million net loss in Q2 2025, mainly driven by non-cash impairment charges, though partially offset by a $473 million gain on sale of Jamaican operations. Adjusted EBITDA turned negative, and revenues declined substantially year-over-year.
Net loss of $557 million driven by $699 million in impairment charges.
Adjusted EBITDA was negative $3.7 million for the quarter.
Revenue fell to $301.7 million from $428.0 million a year ago.
Company booked a $473 million gain from the sale of its Jamaican operations.
The company expects improvements in core earnings driven by new developments and strategic restructuring, but acknowledges liquidity risks and uncertainty around outcomes.